Truist Financial Corp Purchases 551 Shares of STERIS plc (NYSE:STE)

Truist Financial Corp increased its position in STERIS plc (NYSE:STE) by 2.0% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 28,364 shares of the medical equipment provider’s stock after purchasing an additional 551 shares during the period. Truist Financial Corp’s holdings in STERIS were worth $6,236,000 at the end of the most recent reporting period.

Other hedge funds also recently bought and sold shares of the company. Millburn Ridgefield Corp bought a new position in STERIS in the 3rd quarter worth about $25,000. Catalyst Capital Advisors LLC bought a new position in STERIS during the 3rd quarter valued at about $25,000. Global Wealth Management Investment Advisory Inc. bought a new position in STERIS during the 3rd quarter valued at about $49,000. NBC Securities Inc. bought a new position in STERIS during the 3rd quarter valued at about $50,000. Finally, Exchange Traded Concepts LLC bought a new position in STERIS during the 3rd quarter valued at about $54,000. Institutional investors own 94.69% of the company’s stock.

Analyst Ratings Changes

Several equities analysts have issued reports on the stock. JMP Securities restated a “market outperform” rating and set a $265.00 target price on shares of STERIS in a research note on Thursday, February 8th. KeyCorp initiated coverage on shares of STERIS in a research note on Tuesday, February 6th. They set an “overweight” rating and a $253.00 target price on the stock. Stephens reaffirmed an “overweight” rating and set a $250.00 price target on shares of STERIS in a research report on Friday, February 9th. Needham & Company LLC reaffirmed a “hold” rating on shares of STERIS in a research report on Friday, April 12th. Finally, TheStreet raised shares of STERIS from a “c+” rating to a “b” rating in a research report on Wednesday, February 7th. Four research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. According to MarketBeat.com, STERIS has a consensus rating of “Hold” and a consensus price target of $239.60.

STERIS Trading Up 0.8 %

STERIS stock opened at $207.82 on Friday. The firm has a 50 day moving average of $218.46 and a 200 day moving average of $216.13. The firm has a market capitalization of $20.53 billion, a price-to-earnings ratio of 36.40 and a beta of 0.81. STERIS plc has a 12-month low of $185.22 and a 12-month high of $254.00. The company has a current ratio of 2.43, a quick ratio of 1.49 and a debt-to-equity ratio of 0.50.

STERIS (NYSE:STE) last released its earnings results on Wednesday, February 7th. The medical equipment provider reported $2.22 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.17 by $0.05. The company had revenue of $1.40 billion during the quarter, compared to analyst estimates of $1.35 billion. STERIS had a net margin of 10.48% and a return on equity of 13.67%. The firm’s quarterly revenue was up 14.8% compared to the same quarter last year. During the same period in the prior year, the firm posted $2.02 EPS. As a group, research analysts predict that STERIS plc will post 8.67 earnings per share for the current year.

STERIS Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, June 26th. Investors of record on Wednesday, June 12th will be issued a $0.52 dividend. This represents a $2.08 annualized dividend and a yield of 1.00%. The ex-dividend date is Wednesday, June 12th. STERIS’s dividend payout ratio is 36.43%.

STERIS Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.